Skip to main content
. Author manuscript; available in PMC: 2013 Aug 14.
Published in final edited form as: Biochemistry. 2012 Jul 31;51(32):6441–6457. doi: 10.1021/bi300744z

Table 2.

Tabulated UV/Vis absorbance data for azole fragment binding CYP3A4 and CYP2C9.

Soret (nm) α (nm) β (nm) α:β Difference: Peak (nm) Difference: Trough (nm) Absmax (1μM)# Abs390 (1μM)% KD (mM)
CYP3A4* 416 565 534 0.94 --- --- --- --- ---
1,2,3-TRZ 422 565 538 0.77 430 394 0.058 −0.023 14.3 +/− 0.5
1,2,4-TRZ 422 569 537 0.74 432 395 0.0065
0.050
−0.025 KD1=0.0390±0.0071
KD2 = 4.80 ± 0.22
IMZ 424 570 538 0.73 432 407 0.065 −0.027 0.381 +/− 0.011
CYP2C9* 418 569 537 1.1 --- --- --- --- ---
1,2,3-TRZ 420 570 540 0.84 433 411 0.041 --- 10.0 +/− 0.4
1,2,4-TRZ 423 572 542 0.78 437 411 0.023
0.044
--- KD1=0.198±0.040
KD2 = 2.85 ± 0.82
IMZ 427 574 544 0.77 439 413 0.066 --- 0.0989 +/− 0.0018
*

20°C

#

Maximum peak trough intensity normalized to 1 μM

%

Used as an estimate of efficiency of type II ligand to decrease inherent high spin enzyme fraction (type IIa)(24).